Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Nutex Health (NUTX) EBITDA Margin: 2009-2024

Historic EBITDA Margin for Nutex Health (NUTX) over the last 15 years, with FY2024 value amounting to 27.23%.

  • Nutex Health's EBITDA Margin rose 364200.0% to 48.68% in Q3 2025 from the same period last year, while for Sep 2025 it was 36.58%, marking a year-over-year increase of 399100.0%. This contributed to the annual value of 27.23% for FY2024, which is 400600.0% up from last year.
  • Nutex Health's EBITDA Margin amounted to 27.23% in FY2024, which was up 400600.0% from 12.83% recorded in FY2023.
  • Nutex Health's 5-year EBITDA Margin high stood at 55.9% for FY2020, and its period low was 185.41% during FY2022.
  • For the 5-year period, Nutex Health's EBITDA Margin averaged around 12.75%, with its median value being 27.23% (2024).
  • In the last 5 years, Nutex Health's EBITDA Margin surged by 5595600bps in 2020 and then tumbled by -2367700bps in 2022.
  • Annual analysis of 5 years shows Nutex Health's EBITDA Margin stood at 55.9% in 2020, then fell by -8bps to 51.36% in 2021, then plummeted by -461bps to 185.41% in 2022, then surged by 93bps to 12.83% in 2023, then surged by 312bps to 27.23% in 2024.
  • Its EBITDA Margin was 27.23% in FY2024, compared to 12.83% in FY2023 and 185.41% in FY2022.